Drugs / Anti-HBV placenta transfer factor
Trials 1
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 4 | NCT02412319 | Oct 2014 → Dec 2016 | chronic hepatitis B virus infection | Shineway Pharmaceutical Co.,Ltd | Unknown | No outcome recorded |
Evidence & citations 2 cited values
Every value below carries the sentence it was read from. 1 source stands behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | Anti-HBV placenta transfer factor | ClinicalTrials.gov intervention name — accepted as the source's own label NCT02412319 ↗ |
| Route | Intramuscular | “intramuscular injection” NCT02412319 ↗ |